BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 25336623)

  • 21. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases.
    Yoo JH; Choi JH; Choi SM; Lee DG; Shin WS; Min WS; Kim CC
    Clin Infect Dis; 2005 Feb; 40(3):392-8. PubMed ID: 15668862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of serum galactomannan detection for diagnosis of invasive aspergillosis in hematopoietic stem cell transplant recipients].
    Ji Y; Liu DH; Xu LP; Liu KY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):83-6. PubMed ID: 17650666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients.
    Springer J; Morton CO; Perry M; Heinz WJ; Paholcsek M; Alzheimer M; Rogers TR; Barnes RA; Einsele H; Loeffler J; White PL
    J Clin Microbiol; 2013 May; 51(5):1445-50. PubMed ID: 23426930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients.
    Bellanger AP; Millon L; Berceanu A; Grenouillet F; Grenouillet FE; Larosa F; Deconinck E
    Med Mycol; 2015 Sep; 53(7):760-4. PubMed ID: 26162471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
    Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M
    Pediatr Blood Cancer; 2007 Jan; 48(1):28-34. PubMed ID: 16395687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galactomannan and Polymerase Chain Reaction-Based Screening for Invasive Aspergillosis Among High-Risk Hematology Patients: A Diagnostic Meta-analysis.
    Arvanitis M; Anagnostou T; Mylonakis E
    Clin Infect Dis; 2015 Oct; 61(8):1263-72. PubMed ID: 26157047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
    White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
    Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
    Duarte RF; Sánchez-Ortega I; Cuesta I; Arnan M; Patiño B; Fernández de Sevilla A; Gudiol C; Ayats J; Cuenca-Estrella M
    Clin Infect Dis; 2014 Dec; 59(12):1696-702. PubMed ID: 25165088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
    Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
    Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
    Racil Z; Weinbergerova B; Kocmanova I; Muzik J; Kouba M; Drgona L; Masarova L; Guman T; Tothova E; Forsterova K; Haber J; Ziakova B; Bojtarova E; Vydra J; Mudry P; Foralova R; Sejnova D; Mallatova N; Kandrnal V; Cetkovsky P; Mayer J
    Int J Infect Dis; 2013 Feb; 17(2):e101-9. PubMed ID: 23084969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
    Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
    Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients.
    Buchheidt D; Hummel M; Schleiermacher D; Spiess B; Schwerdtfeger R; Cornely OA; Wilhelm S; Reuter S; Kern W; Südhoff T; Mörz H; Hehlmann R
    Br J Haematol; 2004 Apr; 125(2):196-202. PubMed ID: 15059142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
    Ulusakarya A; Chachaty E; Vantelon JM; Youssef A; Tancrède C; Pico JL; Bourhis JH; Fenaux P; Munck JN
    Hematol J; 2000; 1(2):111-6. PubMed ID: 11920178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using the galactomannan antigen assay in the diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.
    Tănase AD; Coliţă A; Mărculescu A; Berteanu C; Streinu Cercel A; Stoica M; Stoica A; Cernea D; Copotoiu S; Brînzaniuc K; Azamfirei L
    Rom J Morphol Embryol; 2012; 53(2):379-82. PubMed ID: 22732810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.
    Maertens J; Verhaegen J; Demuynck H; Brock P; Verhoef G; Vandenberghe P; Van Eldere J; Verbist L; Boogaerts M
    J Clin Microbiol; 1999 Oct; 37(10):3223-8. PubMed ID: 10488181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis.
    White PL; Parr C; Thornton C; Barnes RA
    J Clin Microbiol; 2013 May; 51(5):1510-6. PubMed ID: 23486712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive Aspergillosis in patients with febrile neutropenia.
    Cuenca-Estrella M; Meije Y; Diaz-Pedroche C; Gomez-Lopez A; Buitrago MJ; Bernal-Martinez L; Grande C; Juan RS; Lizasoain M; Rodriguez-Tudela JL; Aguado JM
    J Clin Microbiol; 2009 Feb; 47(2):379-84. PubMed ID: 19109479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.